21 May 2020 --- Industry behemoth Cargill’s health tech arm has signed a multi-year platform agreement with life sciences and microbiome discovery company Eagle Genomics. The collaboration seeks to enable the digital transformation of microbiome and life sciences R&D across Cargill’s global locations. The deployment of the Eagle Genomics’ platform, called e[datascientist], will initially enable Cargill’s Health Technologies business to organize and synthesize additional insights from microbiome data amassed by the company over the past decade.
